Track record · closed signal

Palantir Technologies Inc. (PLTR) — closed signal from October 13, 2025

Partial Published before the outcome was known, scored automatically when the window closed on January 11, 2026.

Predicted vs. what happened

PLTR price · publication thesis → realized outcomesplit-adjusted
$177.58 Published $221.97 Target $177.49 Window close $207.52 Peak
$167.00 – $172.00Entry zone — fair-value band
$177.58Published — price the day we called it
$221.97Target — the price the thesis aimed for
$207.52Peak — highest point inside the window, not a realized return
$177.49Window close — end-of-window price, context only

What happened

Partial

Reached 68% of the predicted growth at its peak, without hitting the target.

Peak price
$207.52
peak on November 3, 2025 — not a realized return
Peak gain
+16.9%
peak, from the publication price
Window close
$177.49
end-of-window price, context only
Days to target
Window
October 13, 2025 – January 11, 2026

The thesis — published October 13, 2025

Predicted growth
+25%
over the measurement window
Target price
$221.97
the price the thesis aimed for
Entry zone
$167.00 – $172.00
the fair-value band we waited for
Price at publication
$177.58
published October 13, 2025
Confidence
68%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

Palantir's stock fell after security worries and insider selling. The company later said the flaw claims were not true and announced a multi-year healthcare contract, showing customers still want its AI tools. Investor interest remains solid, but the price is under pressure. Buying closer to $167-$172 could be more forgiving, and over the next three months the price may work back toward a more typical level.

Primary drivers

  • New healthcare AI deal widens the potential customer base and long-term demand
  • The price dropped quickly while interest from investors stays strong, hinting at a rebound
  • Earlier negative headlines are fading as the company addresses the concerns
  • High price relative to profits makes shares sensitive, causing bigger moves on news

How it played out

PLTR: target was not reached

Lyra published PLTR on 2025-10-13 at 177.58, with expected growth of 25% toward 221.97. The thesis pointed to a healthcare artificial intelligence deal, a fast price drop while investor interest stayed strong, earlier negative headlines fading, and a high price relative to profits that made the shares sensitive to news.

Inside the window, PLTR rose to 207.52 on 2025-11-03, a 16.9% peak gain. It never reached 221.97. By 2026-01-11, it ended at 177.49, almost back where the signal began. The thesis partly played out because the stock rallied, but the target was missed.

What happened during the window

On 2025-11-03, Palantir reported third-quarter revenue of $1.18 billion and raised its full-year revenue outlook to $4.396 billion to $4.4 billion. The same report said adjusted earnings per share were $0.21.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.